Cofounder, 23andMe

Anne Wojcicki co-founded 23andMe after a decade in healthcare investing and serves as CEO. The company’s mission is to help people access, understand, and benefit from the human genome. Commercial and academic researchers benefit from 23andMe’s genetics-based research approach, which can help accelerate discovery to bring about new treatments and cures. Under Wojcicki’s leadership, the company has made significant advances in bringing personalized medicine to the public.


A headshot of Anne Wojcicki